2. Academic Validation
  3. Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling

Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling

  • PLoS One. 2015 Nov 3;10(11):e0142355. doi: 10.1371/journal.pone.0142355.
Ikuo Nakamura,  Kais Zakharia,  Bubu A Banini,  Dalia S Mikhail,  Tae Hyo Kim,  Ju Dong Yang,  Catherine D Moser,  Hassan M Shaleh,  Sarah R Thornburgh,  Ian Walters,  Lewis R Roberts
PMID: 26528545 DOI: 10.1371/journal.pone.0142355
Figures
Products